StockData
Natera, Inc. logo

Natera, Inc.

NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 10/30206% above fair value
$378.92−35.38 (-8.54%)

Close on Nov 2, 2026Market cap $54.62BP/E –Yield –

Natera Total Unconditional Purchase Obligations by Year

Total Unconditional Purchase Obligations ($M) ($M)

Natera Total Unconditional Purchase Obligations: $257M in FY2025, up 50.0% from a year earlier.

Latest, FY2025
257
Period ended Dec 31, 2025
Change on a year earlier
+50.0%
171 in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (2026-02-27) ↗

Total contractual non-cancelable purchase commitments across laboratory sequencing consumables, instruments, cloud computing, and clinical trial sample agreements ($189.20M at Q2 2026).

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedTotal Unconditional Purchase Obligations ($M) ($M)Year on yearSource
FY2025Dec 31, 2025257+50.0%Form 10-K (2026-02-27) ↗
FY2024Dec 31, 2024171+81.2%Form 10-K (2025-02-28) ↗
FY2023Dec 31, 202394.5+20.7%Form 10-K (2024-02-29) ↗
FY2022Dec 31, 202278.4-43.2%Form 10-K (2023-03-01) ↗
FY2021Dec 31, 2021138+81.5%Form 10-K (2022-02-25) ↗
FY2020Dec 31, 202076.0–Form 10-K (2021-02-26) ↗

Breakdown

What makes up total Unconditional Purchase Obligations

Cite this data

StockData. (2026). Natera Total Unconditional Purchase Obligations ($M), annual FY2020–FY2025 [Data set]. Compiled from Natera SEC filings and investor materials. https://stockdatahq.com/stocks/ntra/kpis/purchase-oblig-total

See every metric in the Natera KPI table. Data updated Nov 2, 2026.